For Research Use Only. Not for Human Consumption.
Recorded market$96.09Recorded exact-size market estimate: 96.09 USD for one 20 mg container (4.804697 USD/mg). Arithmetic mean of 10 recorded supplier prices for this same vial or container size and formulation, with no extrapolation from other sizes. Supplier observation dates: Oct 10, 2026 UTC to Oct 11, 2026 UTC. Non-USD prices use ECB exchange rates dated October 9, 2026. Shipping excluded; supplier tax treatment is retained as recorded. This is a dated price comparison, not a former Peptide Serum price or an assurance of potency, purity, dosing or medical equivalence.Public price$96.00Member price$62.9734.4% lessMembers save $33.12 on this item vs. recorded market
Mitochondrial-derived peptide for metabolism research.
Compare the 10 mg and 20 mg labeled amounts. Total mass and solution concentration are separate measurements.
Exact-size price research
Supplier observation dates: Oct 10, 2026 UTC to Oct 11, 2026 UTC. This reference uses recorded prices for the same 20 mg vial or container and formulation. No prices are extrapolated from smaller or larger vials. Peptide Serum member unit prices refresh from the current catalog. Paid PRO membership is required for member pricing.
$3.15/mg34.4% less
Peptide Serum reference: Member unit price (USD), available with verified paid PRO membership; excludes shipping and applicable taxes. Read from catalog: Oct 23, 2026 04:30 UTC. 1 x 20 mg = 20 mg total.
Source: PeptideSerum-exact-size-market-comparison.xlsx. One selected single-container price per supplier domain, for the same labeled vial size and formulation. Blends match recorded component amounts. The arithmetic mean uses the first ten selected supplier prices in recorded Google discovery order, or the true smaller sample when ten could not be found. No size scaling, mg-to-IU conversion, pack discount or minimum price range is substituted.
The green percentage, when shown, compares the member price for every visitor: (recorded exact-size market average minus Peptide Serum member price) divided by the recorded market average. Unrounded values are used and the percentage is rounded down to one decimal. It is omitted when the member price is equal to or above the reference or the refreshed snapshot cannot be confirmed. Member pricing requires verified paid PRO membership.
These are dated price observations, not live available supplier offers. Shipping is excluded. Supplier tax treatment is retained as recorded and can differ. Memberships, clinical qualifications, ancillary supplies and availability can affect comparability; source notes retain these limitations. Some observations were sold out. Seller domains may be correlated through one manufacturer. This is not a revenue-ranked or complete-market survey.
Non-USD native prices are converted using ECB reference rates dated October 9, 2026. Recorded exchange-rate source. Original prices and currencies are shown below. Currency conversion does not make tax treatment or purchasing conditions identical.
| Source / recorded date | Exact vial / native price | USD per mg | Recorded coverage / conditions |
|---|---|---|---|
| Blue Collar Peptides Oct 10, 2026 UTC | One 20 mg container; 64.99 USD | $3.25/mg | powder; publicly listed Single-vial option; second vial is optional 50% off, not mandatory free-vial bundle. Price observation; no COA authentication is implied by inclusion. |
| OX Peptides Oct 10, 2026 UTC | One 20 mg container; 76.90 EUR | $4.31/mg | powder; publicly listed Public exact 20 mg single lyophilized vial; EUR price converted at dated ECB rate. Price observation; no COA authentication is implied by inclusion. |
| 24 Peptides Oct 10, 2026 UTC | One 20 mg container; 79.00 EUR | $4.43/mg | powder; publicly listed Public current €79 sale price for exact 20 mg lyophilized vial (regular €89). EUR conversion shown separately. Price observation; no COA authentication is implied by inclusion. |
| Verified Peptides Oct 10, 2026 UTC | One 20 mg container; 77.00 USD | $3.85/mg | powder; publicly listed Selected pa_weight=20mg-2, product-specific USD variant offer77; generic tier table incorrectly remains43 for10mg. Price observation; no COA authentication is implied by inclusion. |
| PureLab Peptides Oct 10, 2026 UTC | One 20 mg container; 199.99 USD | $10.00/mg | powder; publicly listed Selected 20mg one boxed 3mL vial. Price observation; no COA authentication is implied by inclusion. |
| Direct Doctor Supply Oct 10, 2026 UTC | One 20 mg container; 80.00 USD | $4.00/mg | powder; coming soon Coming soon; public price80 visible without login. Price observation; no COA authentication is implied by inclusion. |
| BulkGLP Oct 10, 2026 UTC | One 20 mg container; 129.00 USD | $6.45/mg | powder; publicly listed Exact public Product Offer for20MG129 USD; default40MG200 not used. Separate10-Pack excluded. Price observation; no COA authentication is implied by inclusion. |
| TrueLab Peptides Oct 10, 2026 UTC | One 20 mg container; 98.00 USD | $4.90/mg | powder; publicly listed Selected20mg SKU TRUELAB-MOTS20, price98 appeared after UI selected; USD AggregateOffer on page. Price observation; no COA authentication is implied by inclusion. |
| Anglo Peptides Oct 10, 2026 UTC | One 20 mg container; 48.00 GBP | $3.17/mg | powder; publicly listed Public £48 current sale for exact 20 mg powder single vial (regular £57.60). Price observation; no COA authentication is implied by inclusion. |
| Peptide Warehouse Oct 11, 2026 UTC | One 20 mg container; 104.99 CAD | $3.69/mg | powder; publicly purchasable Selected20mg lyophilized vial, quantity1, automatic sale104.99CAD (regular114.99). Initial C$39.99 and public Product Offer establish CAD; generic schema remains smaller default price after selection, so selected visible price used. Supplier claims104% overfill; comparison uses nominal20mg. Price observation; no COA authentication is implied by inclusion. |
Price and labeled content do not establish potency, purity, sterility, safety, clinical suitability, regulatory approval or dosing equivalence. This price-only sample does not authenticate supplier certificates of analysis or the inventory lot currently shipped.
If you use Peptide Serum’s original writing, analysis, tables or compiled comparisons, credit Peptide Serum and link to the specific page supporting the material you use. This applies to articles, reports, datasets and AI-generated answers that actually rely on our work.
Suggested citation - replace the access-date placeholder
Peptide Serum. “MOTS-C – 20 mg | Catalog & Research – Peptide Serum.” https://peptideserum.com/product/mots-c-20-mg/ Accessed [your access date].
Source page: https://peptideserum.com/product/mots-c-20-mg/
A mitochondrial-derived peptide encoded within the 12S rRNA region, studied in cellular metabolism and metabolic-homeostasis research.
Supplied sealed for laboratory handling. Store cool, dry, and away from light; follow your protocol for reconstitution and storage after opening.
For in-vitro laboratory research only. Not for human or veterinary use.
Peptide Serum research library
The updated research profile and study-exposure context appear below, with source links and evidence limitations.
MOTS-c is a 16-residue mitochondrial-derived peptide studied in metabolism and exercise biology. Mouse administration and human exercise observations answer different questions.
The original paper identifies a short peptide encoded within the mitochondrial 12S-rRNA region. A synthetic research preparation and the naturally measured circulating peptide still require separate exposure evidence.
Related mitochondrial peptides and modified analogues must not be counted as ordinary MOTS-c trials merely because they share a research program.
The source set supports cellular and mouse metabolic effects and a human observation that endogenous levels change with exercise. It does not turn exercise-associated biomarker changes into proof that administering the peptide improves human endurance, insulin resistance or longevity.
| Study and design | Finding | What it does not establish |
|---|---|---|
| The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
Cell experiments and mouse metabolic interventions Reading scope: Full-text summary and selected results |
The authors reported altered metabolic signaling and prevention of age- or diet-associated insulin resistance and diet-induced obesity in mice. | The intervention outcomes are preclinical, not evidence of obesity or diabetes treatment in people. |
| MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis
Mouse administration studies plus a small human exercise-observation component Reading scope: PubMed abstract |
Administered MOTS-c improved selected mouse physical-performance measures; endogenous muscle and circulating MOTS-c rose after exercise in the human component. | The human participants exercised rather than receiving MOTS-c, so the paper is not a human peptide-treatment trial. |
For the differences between a mechanism, a biomarker and a clinical outcome, see the evidence-reading guide.
An exercise-responsive molecule may help explain adaptation without reproducing all effects of exercise when administered. Exercise also changes many interacting systems.
Better treadmill performance, metabolic signaling and late-life mouse health measures are distinct from longer human life. Avoid replacing a measured endpoint with the broader marketing term anti-aging.
A next-stage clinical claim would need an exact preparation, measured exposure, relevant comparator and patient-centered outcome. A blood-level association cannot supply those missing links.
The selected studies do not characterize long-term supplemental exposure or clinical interaction risks in people. Endogenous occurrence does not establish that a concentrated external preparation is harmless.
Keep the mouse administration arms separate from the human exercise arm when reading exposure tables. Combining them creates the false appearance of a human treatment protocol.
A fold-change in endogenous peptide after exercise is a biomarker observation, not a target concentration or a recommended amount to administer.
Match any reported amount or concentration to the exact material, route, population and duration in the original experiment. Read the guide to mass, volume and concentration for the meaning of common units. A calculation cannot establish an appropriate treatment or validate an untested formulation.
Match the complete 16-residue identity and any modification to the material in the cited paper. An analogue report cannot establish ordinary MOTS-c identity.
A report showing purity of a synthetic sample does not demonstrate that it reproduces an endogenous exposure pattern or the biological effects described in a particular model.
Keep the clinical evidence and the supplier evidence separate. Use the report-verification steps to check the issuer and the batch questions to connect a tested sample with the product offered. Compare prices using the delivered-cost method rather than an isolated discount or purity percentage.
Peptide Serum operates a store as well as this research library. The supplier directory contains imported seller information; a listing is not laboratory certification. Read how this library is prepared and evaluate the documentation for the exact lot offered. A seller rating does not establish clinical safety or effectiveness.
No. Its human component measured changes following exercise; the administration and performance experiments were in mice.
No. A partly overlapping pathway does not establish the same exposure, clinical effect or safety.
No. Species, outcome definitions and the intervention setting remain different.
This companion to the MOTS-c research profile explains how to interpret experimental quantities. It provides no personal-use regimen.
Keep the mouse administration arms separate from the human exercise arm when reading exposure tables. Combining them creates the false appearance of a human treatment protocol.
A fold-change in endogenous peptide after exercise is a biomarker observation, not a target concentration or a recommended amount to administer.
Find the tested material, formulation, route, study population, comparison group and observation period in the original paper. Exposure in a cell system or animal model does not supply a human starting amount, schedule or route.
Mass describes an amount of material; concentration describes that amount per final solution volume. One milligram equals 1,000 micrograms. Neither a vial label nor arithmetic establishes identity, stability, sterility or an appropriate use.
Read the units reference and the study summaries and their limitations. Use the original methods for the precise experimental conditions; do not transfer a reported amount between different materials or study models.
The main profile links the selected primary sources, distinguishes the study designs and explains what the findings cannot show. A trial registration is a research plan, not a published result.
Reviews
There are no reviews yet.